Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZZKZ vs Doxepin in Refractory Functional Dyspepsia
NCT05107999Unknown
- Sponsor
- Renji Hospital
- Start
- Feb 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Zhizhu Kuanzhong in functional dyspepsia (FD) (2 arms), sponsored by Renji Hospital. Primary endpoints: Leeds Dyspepsia Questionnaire at 4 weeks, Patient Health Questionnaire-9 at 4 weeks and 1 more. Status: unknown.
02
Drugs
Zhizhu Kuanzhong
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05107999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05107999.